Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)

被引:1
|
作者
Wieckiewicz, Gniewko [1 ]
Danel, Dariusz [2 ]
Piegza, Magdalena [1 ]
Gorczyca, Piotr [1 ]
Pudlo, Robert [1 ]
机构
[1] Slaski Uniwersytet Med Katowicach, Wydzial Nauk Med Zabrze, Katedra & Oddzial Klin Psychiat, Ul Pyskowicka 49, PL-42612 Katowice, Poland
[2] Polish Acad Sci, Inst Immunol & Terapii Doswiadczalnej Ludwika Hir, Poznan, Poland
关键词
HADS; MDMA; GHQ-28; SUBJECTIVE EXPERIENCES; CARE;
D O I
10.12740/PP/OnlineFirst/134317
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aim. MDMA is one of the most commonly used drugs in the world. Clinical studies are currently being conducted around the world on the use of this substance in the treatment of PTSD and alcoholism. However, little demographic information is available on users who use the substance for non-medical purposes. The aim of the study was to determine basic demographic and health characteristics with validated tools. Method. The authors prepared an original questionnaire on the demography of MDMA users and combined it with the General Health Questionnaire-28 (GHQ-28) and the Hospital Anxiety and Depression Scale (HADS). The survey was sent to Polish MDMA users via the Internet. Results. 304 responses were received from people over 18 years of age. MDMA is widespread among young adults, in many different places of residence and regardless of gender. The users take MDMA in both pill and crystal form and very rarely test drugs bought from a dealer. Most users feel that MDMA has had a good impact on their lives. Conclusions. MDMA is rarely used as the only psychoactive substance. MDMA users rate their health higher than people using other psychoactive substances.
引用
收藏
页码:1109 / 1130
页数:22
相关论文
共 50 条
  • [1] Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)
    Morimoto, BH
    Lovell, S
    Kahr, B
    [J]. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 229 - 231
  • [2] Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
    Back-Madruga, C
    Boone, KB
    Chang, L
    Grob, CS
    Lee, A
    Nations, H
    Poland, RE
    [J]. CLINICAL NEUROPSYCHOLOGIST, 2003, 17 (04) : 446 - 459
  • [3] Language function in abstinent 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") users
    Campbell, Z
    Zakzanis, KK
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2003, 18 (07) : 721 - 721
  • [4] Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
    Back-Madruga, C
    Boone, K
    Chang, L
    Grob, C
    Poland, R
    Lee, A
    Nations, H
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2003, 18 (07) : 720 - 720
  • [5] Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users
    Groth-Marnat, Gary
    Howchar, Hennedy
    Marsh, Ali
    [J]. PERCEPTUAL AND MOTOR SKILLS, 2007, 104 (01) : 43 - 55
  • [6] Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
    Wunderli, Michael D.
    Vonmoos, Matthias
    Treichler, Lorena
    Zeller, Carmen
    Dziobek, Isabel
    Kraemer, Thomas
    Baumgartner, Markus R.
    Seifritz, Erich
    Quednow, Boris B.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (04): : 333 - 344
  • [7] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users
    McCann, Una D.
    Edwards, Robert R.
    Smith, Michael T.
    Kelley, Kristen
    Wilson, Michael
    Sgambati, Francis
    Ricaurte, George
    [J]. PSYCHOPHARMACOLOGY, 2011, 217 (04) : 475 - 484
  • [8] Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users:: a controlled study
    McCann, UD
    Mertl, M
    Eligulashvili, V
    Ricaurte, GA
    [J]. PSYCHOPHARMACOLOGY, 1999, 143 (04) : 417 - 425
  • [9] Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study
    U. D. McCann
    Melissa Mertl
    Victoria Eligulashvili
    George A. Ricaurte
    [J]. Psychopharmacology, 1999, 143 : 417 - 425
  • [10] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users
    Una D. McCann
    Robert R. Edwards
    Michael T. Smith
    Kristen Kelley
    Michael Wilson
    Francis Sgambati
    George Ricaurte
    [J]. Psychopharmacology, 2011, 217 : 475 - 484